Renal ischemia-reperfusion injury: An inescapable event affecting kidney transplantation outcome

Folia Microbiologica

Volumn 46, Issue 4, 2001, Pages 267-276

  Bohmova R ^a   Viklicky O ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

GRAFT REJECTION; HUMAN; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; PATHOLOGY; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; TREATMENT OUTCOME; VASCULARIZATION;

GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0035749383     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815613     Document Type: Article

References (69)

1. ADAMS D.H., LLOYD A.R.: Chemokines: leukocyte recruitment and activation cytokines. Lancet 349, 490-495 (1997).
2. AZUMA H., NADEAU K., TAKADA M., MACKENZIE H.S., TILNEY N.L.: Cellular and molecular predictors of chronic renal dysfunction after initial ischemia-reperfusion injury of a single kidney. Transplantation 64, 190-197 (1997).
3. BAGGE U., AMUNDSON B., LAURITZEN C.: White blood cells deformability and plugging of skeletal muscle capillaries in hemorrhagic shock. Acta Physiol. Scand. 180, 159-163 (1980).
4. BAYATI A., NYGREN K., KALLSKOG O., WOLGAST M.: The long term outcome of postischemic acute renal failure in the rat. Ren.Fail. 14, 333-336 (1992).
5. BEEKHUIZEN H., VAN DE GEVEL J.S.: Endothelial cell adhesion molecules in inflammation and postischemic repertusion injury. Transplant. Proc 30, 4251-4256 (1998).
6. BOOM H., MALLAT M.J.K., DE FIJTER J.W., ZWINDERMAN A.H., PAUL L.C.: Delayed graft function influences renal function, but not survival. Kidney Internat. 58, 859-866 (2000).
7. BROWN Z., ROBSON R.L., WESTWICK J.: Regulation and expression of chemokines: potential role in glomerulonephritis J.Leucoc.Biol. 59, 75-80 (1996).
8. CARMELLINI M.,VISTOLI F., BOGGI U., BELLINI., MOSCA F.: Delayed graft function incidence as predictive variable of survival kidney grafts retrieved from elderly donors. Transplant.Proc 32, 128-130 (2000).
9. CAVANAGH S.P., GOUGH M.J., HOMER-VANNIASINKAM S.: The role of the neutrophil in ischaemia-reperfusion injury: potential therapeutic interventions. Cardiovasc.Surg. 6, 112-118 (1998).
10. CHAREANDEE C., HERMAN W.H., HRICIK D.E., SIMONSON M.S.: Elevated endothelin-1 in tubular epithelium is associated with renal allograft rejection. Am.J.Kidn.Dis. 36, 541-549 (2000).
11. DONG J., PRATT J.R., SMITH R.A.G., DODD I., SACKS S.H.: Strategies for targeting complement inhibitors in ischaemia-reperfusion injury. Mol.Immunol. 36, 957-963 (1999).
12. DONNA L., GRANGER D.N.: Pathophysiology of ischaemia-reperfusion injury. J.Pathol. 190, 255-266 (2000).
13. DRAGUN D., TULLIUS S.G., PARK J.K., MAASCH C., LUKITSCH I., LIPPOLDT A., GROSS V., LUFT F.C., HALLER H.: ICAM-1 antisense oligodeoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Internat. 54, 590-602 (1998).
14. DRAGUN D., HOFF U., PARK J.K., QUN Y., SCHNEIDER W., LUFT F.C., HALLER H.: Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. Kidney Internat. 58, 2166-2177 (2000).
15. FORBES J.M., HEWITSON T.D., BECKER G.J. JONES C.L.: Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Kidney Internat. 59, 1333-1341 (2001)
16. ). GOLIGORSKY M.S., LIEBERTHAL W., RACUSEN L., SIMON E.E.: Integrin receptors in renal tubular epithelium: new insights into pathophysiology of acute renal failure Am.J.Physiol. 264, F1-F8 (1993).
17. GRANGER D.N.: Physiology and patophysiology of the microcirculation. Prog.Cardiovasc.Med. 3, 123-140 (1998).
18. GRANGER D.M.: Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury Am.J.Physiol. 255, H1269-H1275 (1998).
19. GRONE H.J., WEBER C., WEBER K., GRONE E.F., RABELINK T., KLIER C.M., WELLS T.N., PROUDFOOD A.E., SCHLONDORFF D., NELSON P.J.: Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J. 13, 1371-1383 (1999).
20. JONES E.A., SHOSKES D.A.: The effect of mycophenolate mofetil and polyphenolic biotlavonoids on renal ischemia-reperfusion injury and repair. J. Urol. 163, 999-1004 (2000).
21. KOHAN D.E.: Endothelins in the normal and diseased kidney. Am.J.Kidney Dis. 29, 2-26 (1997).
22. KON V., HUNLEY T.E., FOGO A.: Combined antagonism of endothelin A/B receptors link endothelin to vasoconstriction whereas angio-tensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats. Transplantation 60, 89-95 (1995).
23. KORTHUS R.J., GUTE D.C.: Adhesion molecule expression in postischemic microvascular dysfunction: activity of micronized purified flavonoid fraction. J. Vasc.Res 36 (Suppl 1 ), 15-23 (1999).
24. KRISHNASWAMY G., KELLEY J., YERRA L., SMITH J.K., CHI D.S.: Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J.Interf.Cytok.Res. 19, 91-104 (1999).
25. LERMAN A., BURNETT J.C. Jr.: Intact and altered endothelium in regulation of vasomotion. Circulation 86 (Suppl. 2), 12-19 (1992).
26. LOPEZ-FARRÉ A., RIESCO A., ESPINOSA G., DIGIUNI E., CERNADAS M.R., ALVAREZ V., MONTON M., RIVAS F., GALLEGO M.J., EGIDO J.: Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart Circulation 88, 1166-1171 (1993).
27. MANCINI M.C., EVANS J.T.: Role of platelet-derived growth factor in allograft vasculopathy. Ann.Surg. 231, 682-688 (2000).
28. MARTIN X., DA SILVA M., VIRIEUX S.R., HADJ AISSA A., BUFFET R., TIOLLIER J., DUBERNARD J.M.: Protective effect of an anti-LFA-1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation. Transplant. Proc. 32, 481 (2000).
29. MASON J., WELSCH J., TORHORST J.: The contribution of vascular obstruction to the functional defect that follows renal ischemia. Kidney Internat. 31, 65-71 (1987).
30. MASSBERG S., MESSMER K.: The nature of ischemia-reperfusion injury. Transplant.Proc. 30, 4217-4223 (1998).
31. MOLITORIS B.A., MARRS J.: The role of adhesion molecules in ischemic acute renal failure. Am.J.Med. 106, 583-592 (1999).
32. NAKAGAWA T., SASAHARA M., HANEDA M., KATAOKA H., NAKAGAWA H., YAGI M., KIKKAWA R., HAZAMA F.: Role of PDGF B-chain and PDGF receptores in rat tubular regeneration after acute injury Am.J.Pathol. 155, 1689-1699 (1999).
33. NICHOLSON-WELLER A., HALPERIN J.A.: Membrane signaling by complement C5b-9, the membrane attack complex. Immun.Res. 12, 244-257 (1993).
34. OBERBAUER R., ROHRMOSER M., REGELE H., MUHLBACHER F., MAYER G.: Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J.Am.Soc.Nephrol. 10, 2006-2013 (1999).
35. OJO A.O., WOLFF R.A., HELD P.J., PORT F.K., SCHMOUDER R.L.: Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 63, 968-997 (1997).
36. ONG A.C.M., FINE L.G.: Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. AmJ.Kidney Dis. 23, 205-209 (1994).
37. PATTISON J., NELSON P.J., HUIE P., VON LUETTICHAU I., FARSHID G., SIBLEY R.K., KRENSKY A.M.: RANTES chemokine expression in cell-mediated transplant rejection of the kidney Lancet 343, 209-211 (1994).
38. PAUL L.C., HAYRI P., FOEGH M., DENNIS J.R., MIHATSCH M.J., LARSSON E., FELLSTROM B.: Diagnostic criteria for chronic rejection/accelerated graft atheroslerosis in heart and kidney transplants: proposal from the 4th Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs Transplant.Proc. 25, 2020-2021 (1993).
39. PAUL L.C., SAITO K., DAVIDOFF A., BENEDIKTSSON H.: Growth factor transcripts in rat renal transplants. AmJ.Kidney Dis. 28, 441-450 (1996).
40. PENFIELD J.G., WANG Y., Li S., KIELAR M.A., SICHER S.C., JEYARAJAH D.R., LU C.Y.: Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney. Kidney Internat. 56, 1759-1769 (1999).
41. RABB H., MENDIOLA C.C., DIETZ J., SABA S.R., ISSEKUTZ T.B., ABANILLA F., BONVENTRE J.V., RAMIREZ G.: Role of CD11a and CD11b in ischemic acute renal failure in rats. Am.J.Physiol. 267, 1052-1058 (1994).
42. RABB H., MENDIOLA C.C., SABA S.R., DIETZ J., SMITH C.W., BONVENTRE J.V., RAMIREZ G.: Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury Biochem.Biophys.Res.Commun. 211, 67-73 (1995).
43. RIGOTTI P., MORPURGO E., COMANDELLA M.G., PITTONI G., BALDAN N., GANZ E., PIAZZA L., CAPALBO M., VALENTE M.L., ANCONA E.: Non-heart beating donors: an alternative organ source in kidney transplantation Transplant.Proc. 23, 2579-2580 (1991).
44. ROBERTSON H., MORLEY A.R., TALBOT D., CALLANAN K., KIRBY J.A.: Renal allograft rejection: β-chemokine involvement in the development of tubulitis. Transplantation 69, 684-687 (2000).
45. ROBERTSON H., WHEELER J., KIRBY J.A., MORLEY A.R.: Renal allograft rejection: in situ demonstration of cytotoxic intratubular cells. Transplantation 61, 1546-1551 (1996).
46. RUBIN B.B., SMITH A., LIAUW S., ISENMAN D., ROMASCHIN A.D., WALKER P.M.: Complement activation and white cells sequestration in postischaemic skeletal muscle. Am.J.Physiol. 259, H525-H531 (1990).
47. SAKURAI H., HISADA Y., UENO M., SUGIURA M., KAWASHIMA K., SUGITA T.: Activation of transcription factor NFκB in experimental glomerulonephritis in rats. Biochim.Biophys.Acta 1316, 132-138 (1996).
48. SCHRECK R., ALBERMANN K., BAEUERLE P.A.: Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad.Res.Commun. 17, 221-237 (1992).
49. SHACKLETON C.R.: Upregulation of major histocompatibility complex - expression under ischemic conditions in experimental models. Transplant.Proc. 30, 4264-4266 (1998).
50. SHOSKES D.A, PARFREY N.A., HALLORAN P.F.: Major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 49, 201 (1990).
51. SHOSKES D.A.: Nonimmunological renal allograft injury and delayed graft function: clinical strategies for prevention and treatment. Transplant.Proc. 32, 766-768 (2000).
52. SONG A., NIKOLCHEVA T., KRENSKY A.M.: Transcriptional regulation of RANTES expression in T lymphocytes. Immunol.Rev. 177, 236-245 (2000).
53. SOUTHARD J.H., VAN GULIK T.M., AMETANI M.S., VREUGDENHILL P.K., LINDELL S.L., PIENAAR B.L., BELZER P.O.: Important components of UW solution. Transplantation 49, 251-257 (1990).
54. SULLIVAN G.W., SAREMBOCK I.J., LINDEN J.: The role of inflammation in vascular diseases. J.Leukoc.Biol 67, 591-602 (2000).
55. SZAB̀O A., HEEMANN U.: Ischemia-reperfusion injury and chronic allograft rejection. Transplant.Proc. 30, 4281-4284 (1998).
56. TAKADA M., CHANDRAKER A., NADEAU K.C., SAYEGH H., TILNEY N.L.: The role of the B7 costimulatory pathway in experimental cold ischemia-reperfusion injury. J.Clin.Invest. 100, 1199-1203 (1997).
57. TAKADA M., NADEAU K.C., SHAW G.D., TILNEY N.L.: Prevention of late renal changes after initial ischemia-repertusion injury by blocking early selectin binding. Transplantatton 64, 1520-1525 (1997).
58. TILNEY N.L., GUTTMANN R.D.: Effects of initial ischemia-reperfusion injury on the transplanted kidney. Transplantation 64, 945-947 (1997).
59. TILNEY N.L., KUSAKA M., PRATSCHKE J., WILHELM M.: Chronic rejection. Transplant.Proc. 30, 1590-1594 (1998).
60. TSAO P.S., AOKI A., LEFER D.J., JOHNSON G.D., LEFER A.M.: Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82, 1402-1412 (1990).
61. TULLIUS S.G., TILNEY N.L.: Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 59, 313-318 (1995).
62. VENKATACHALAM M.A., BERNARD D.B., DONOHOE J.F., LEVINSKY N.G.: Ischemic damage and repair in the rat proximal tubule: differences among S1, S2 and S3 segments. Kidney Internat. 14, 31-49 (1978).
63. VOS I.H.C., GOVERS R., GRÖNE H.J., KLEIJ L., SCHURINK M., DE WEGER R.A., GOLDSCHMEDING R., RABELINK T.J.: NFκB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J. 14, 815-822 (2000).
64. WEIGHT S.C., BELL P.R.F., NICHOLSON M.L.: Renal ischaemia-reperfusion injury Brit.J.Surg. 83, 162-170 (1996).
65. WEISS S.J.: Tissue desctruction by neutrophils. New Engl.J.Med. 320, 365-375 (1989).
66. WILHELM M.J., KUSAKA M., PRATSCHKE J., TILNEY N.L.: Chronic rejection: increasing evidence for the importance of allogen-independent factors. Transplant.Proc 30, 2402-2406 (1998).
67. WILHELM S.M., SIMONSON M.S., ROBINSON A.V., STOWE N.T., SCHULAK J.A.: Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Internat. 55, 1011-1018 (1999).
68. WILHELM S.M., STOWE N.T., ROBINSON A.V., SCHULAK J.A.: The use of the endothclin receptor antagonist, tezosentan, before or after renal ischemia protects renal function. Transplantation 71, 211-216 (2001).
69. YANAGISAWA M., KURIHARA H., KIMURA S., TOMOBE Y., KOBAYASHI M., MITSUI Y., YAZAKI Y., GOTO K., MASAKI T.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415 (1988).